Accuray Incorporated (ARAY) vs Nephros, Inc. (NEPH)
A side-by-side comparison of Accuray Incorporated and Nephros, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARAY
Accuray Incorporated
$0.29HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT
NEPH
Nephros, Inc.
$3.69HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT
Total return — ARAY vs NEPH
growth of $100 · dividends reinvested · last 10yARAY -94.9% (-25.7%/yr)NEPH +6.6% (+0.6%/yr)NEPH compounded faster over this window
Log scale — wide-divergence pair
ARAY NEPH
ARAY vs NEPH: by the numbers
- •NEPH is the larger company ($40M vs $35M market cap).
- •NEPH is profitable (8.38% net margin) while ARAY runs a net loss (-12.24%).
- •NEPH grew revenue faster over the past five years (16.99% vs 0.28% CAGR).
Metrics side by side
Valuation
| Metric | ARAY | NEPH |
|---|---|---|
| P/E ratio | N/A | 23.25 |
| Forward P/E | N/A | 23.55 |
| P/S ratio | 0.09 | 1.93 |
| P/B ratio | 0.83 | 3.35 |
| EV / EBITDA | N/A | 20.53 |
Profitability
| Metric | ARAY | NEPH |
|---|---|---|
| Gross margin | 27.73% | 60.31% |
| Operating margin | -6.58% | 7.92% |
| Net margin | -12.24% | 8.38% |
| ROE | -117.97% | 14.51% |
| ROIC | -10.09% | 12.67% |
Growth (annualized)
| Metric | ARAY | NEPH |
|---|---|---|
| Revenue CAGR (5Y) | 0.28% | 16.99% |
| Total return CAGR (5Y) | -39.94% | -15.93% |
Frequently asked
- Which has grown faster, ARAY or NEPH?
- Over the past five years, NEPH grew revenue faster — ARAY at a 0.28% CAGR versus NEPH at 16.99%.
- Is ARAY or NEPH more profitable?
- NEPH runs the higher net margin — ARAY at -12.24% versus NEPH at 8.38%.
- How have ARAY and NEPH total returns compared?
- Over the past 10 years, ARAY delivered -25.77% and NEPH delivered 1.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Nephros P/E ratioAccuray ROENephros ROEAccuray operating marginNephros operating marginAccuray revenue growthNephros revenue growthAccuray free cash flowNephros free cash flow
Accuray & Nephros appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.